144 related articles for article (PubMed ID: 8240744)
1. Cancer.
Curr Opin Immunol; 1993 Oct; 5(5):805-35. PubMed ID: 8240744
[No Abstract] [Full Text] [Related]
2. [New antigens induced by oncogenic viruses].
Kosiakova NP
Usp Sovrem Biol; 1982; 93(3):433-47. PubMed ID: 7051606
[No Abstract] [Full Text] [Related]
3. A fresh look at tumor immunosurveillance and immunotherapy.
Smyth MJ; Godfrey DI; Trapani JA
Nat Immunol; 2001 Apr; 2(4):293-9. PubMed ID: 11276199
[TBL] [Abstract][Full Text] [Related]
4. Tumor immunology.
Stevenson H; Tsang KY
Immunol Ser; 1993; 58():497-515. PubMed ID: 8424991
[No Abstract] [Full Text] [Related]
5. Development of vaccines against self-antigens: the p53 paradigm.
Chada S; Mhashilkar A; Roth JA; Gabrilovich D
Curr Opin Drug Discov Devel; 2003 Mar; 6(2):169-73. PubMed ID: 12669451
[TBL] [Abstract][Full Text] [Related]
6. [Cancer and human viruses. Advances and perspectives].
Carrada Bravo T
Bol Med Hosp Infant Mex; 1982 Sep; 39(9):588-91. PubMed ID: 7138636
[No Abstract] [Full Text] [Related]
7. Immunoprevention of cancer: time to reconsider timing of vaccination against cancer.
Spisek R
Expert Rev Anticancer Ther; 2006 Dec; 6(12):1689-91. PubMed ID: 17181481
[No Abstract] [Full Text] [Related]
8. [Immunology in the diagnosis of cancer].
Oettgen HF
Internist (Berl); 1975 May; 16(5):199-205. PubMed ID: 1097358
[No Abstract] [Full Text] [Related]
9. About human tumor antigens to be used in immunotherapy.
Lucas S; Coulie PG
Semin Immunol; 2008 Oct; 20(5):301-7. PubMed ID: 18395462
[TBL] [Abstract][Full Text] [Related]
10. Animal models of tumor immunity, immunotherapy and cancer vaccines.
Ostrand-Rosenberg S
Curr Opin Immunol; 2004 Apr; 16(2):143-50. PubMed ID: 15023405
[TBL] [Abstract][Full Text] [Related]
11. Cyclin B1 and other cyclins as tumor antigens in immunosurveillance and immunotherapy of cancer.
Egloff AM; Vella LA; Finn OJ
Cancer Res; 2006 Jan; 66(1):6-9. PubMed ID: 16397206
[TBL] [Abstract][Full Text] [Related]
12. Cancer vaccination. Politically incorrect viruses.
Parham P
Nature; 1994 Apr; 368(6471):495-6. PubMed ID: 8139680
[No Abstract] [Full Text] [Related]
13. Immunotherapy and gene therapy of cancer using antibodies or their genes against tumor-associated antigens.
Kuroki M; Shibaguchi H; Imakiire T; Uno K; Shirota K; Higuchi T; Shitama T; Yamada H; Hirose Y; Nagata A; Kuroki M
Anticancer Res; 2003; 23(6a):4377-81. PubMed ID: 14666724
[TBL] [Abstract][Full Text] [Related]
14. [Tumor antigens recognized by T-lymphocytes in human cancers. New advances and therapeutic perspectives].
Gaugler B; Olive D
Pathol Biol (Paris); 1998 Dec; 46(10):771-8. PubMed ID: 9922993
[TBL] [Abstract][Full Text] [Related]
15. The immune defense system. 3. Neoplasia.
McNutt DR
Rev Bras Pesqui Med Biol; 1974; 7(3):309-19. PubMed ID: 4278759
[No Abstract] [Full Text] [Related]
16. Tumor immunology at the service of cancer immunotherapy.
Finn OJ
Curr Opin Immunol; 2004 Apr; 16(2):127-9. PubMed ID: 15023402
[No Abstract] [Full Text] [Related]
17. Tumour-associated surface antigens.
Pasternak G; Milleck J; Pasternak L; Lageman A; Micheel B
Folia Biol (Praha); 1980; 26(1):1-16. PubMed ID: 6988238
[No Abstract] [Full Text] [Related]
18. [The function of tumor specific antigen (MAGE) in tumor immunotherapy].
Fang JB; Wang L
Sheng Li Ke Xue Jin Zhan; 2005 Jul; 36(3):273-5. PubMed ID: 16270835
[No Abstract] [Full Text] [Related]
19. T-cell epitope peptide vaccines.
Elsawa SF; Rodeberg DA; Celis E
Expert Rev Vaccines; 2004 Oct; 3(5):563-75. PubMed ID: 15485336
[TBL] [Abstract][Full Text] [Related]
20. Unique tumor antigens: evidence for immune control of genome integrity and immunogenic targets for T cell-mediated patient-specific immunotherapy.
Sensi M; Anichini A
Clin Cancer Res; 2006 Sep; 12(17):5023-32. PubMed ID: 16951217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
